The PD-1/PD-L1 pathway, increasingly recognized for its role in CRC, suppresses cytotoxic lymphocyte activity, facilitating immune escape (Chen et al., 2017; Wu et al., 2022). This evidence concerns the gene CD274 and colorectal carcinoma.